- Personalized medicine: factors influencing reimbursementLisa M Meckley
Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, 800 Washington St, 63, Boston, MA 02111, USA
Health Policy 94:91-100. 2010..Personalized medicine (PM) has attracted tremendous interest, but yielded few marketed products. We examined factors influencing the reimbursement of existing PM technologies...
- The adoption of cost-effectiveness acceptability curves in cost-utility analysesLisa M Meckley
Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts 02111, USA
Med Decis Making 30:314-9. 2010..g., life-years or quality-adjusted life-years gained)...
- Risk-sharing arrangements that link payment for drugs to health outcomes are proving hard to implementPeter J Neumann
Center for Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA
Health Aff (Millwood) 30:2329-37. 2011..For the foreseeable future, they are likely to remain the exception as drug companies pursue payment models unconnected to data collection or performance assessment...